Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Amnio-Maxx: later-stage trial registry

1 of 1 indexed Amnio-Maxx trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Amnio-Maxx: 1 US clinical trial tracked, 1 recruiting.

Amnio-Maxx is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Royal Biologics, running 1 of these trials.

Enrollment posture brief

Registry condition amnio-maxx

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Amnio-Maxx (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Amnio-Maxx

Amnio-Maxx lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Amnio-Maxx on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Amnio-Maxx is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Royal Biologics 1 trials

Named interventions

Most-linked intervention names on Amnio-Maxx records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Standard of Care (Investigator Choice) Other
1 trials
Amnio-Maxx® Dual Layer Amnion Patch Biological
1 trials

US sites by state

Facility locations filed on Amnio-Maxx trials. A trial with sites in several states counts in each.

Texas 1 trials
Oklahoma 1 trials
New York 1 trials
Nebraska 1 trials
Georgia 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Amnio-Maxx page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Amnio-Maxx condition card totals 1 registered trials; most-linked intervention Standard of Care (Investigator Choice); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.